FDA issued a Warning Letter to Amgen, Inc. on 5/9/2003 for a previous inspection.
483 Amgen Jun 2004

483 Amgen Jun 2004

Robert Tollefsen FDA, Paula Trost FDA$595.00 - Available Now

FDA investigators audited the Amgen - Boulder, CO, United States facility and issued inspectional observations (via FDA 483) on 17 Jun 2004.

Product details

  • Category: Human Drugs
  • Inspection end: 17 Jun 2004
  • Location: Boulder, United States
  • FEI: 3003072024
Add To Cart